1.
J Hosp Med
; 15: 538-539, 2020 07.
Artículo
en Inglés
| MEDLINE
| ID: mdl-32816669
RESUMEN
Viral testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly early in the COVID-19 pandemic, was limited by supply of reagents. We pooled nasopharyngeal samples from patients at low risk of SARS-CoV-2 infection in groups of 3 for testing. Three weeks of testing using this strategy resulted in 530 patient tests in 179 cartridges; 4 positive test groups required the use of 11 additional cartridges with an overall positive rate of 0.8% in a low-risk population. This strategy resulted in the use of 340 fewer cartridges than if each test were performed on one patient sample. Pooled testing of low-risk populations allows for continued testing even when supplies are relatively scarce.
Asunto(s)
Betacoronavirus/genética , Infecciones por Coronavirus/diagnóstico , ADN Viral/análisis , Pruebas Genéticas/métodos , Pacientes Internos , Pandemias , Neumonía Viral/diagnóstico , COVID-19 , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Humanos , Neumonía Viral/epidemiología , Neumonía Viral/virología , SARS-CoV-2
2.
J Hosp Med
; 16(12): 768, 2021 12.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34798002